OncoSec Presents Clinical Overview of Comprehensive Immune Monitoring Data Demonstrating Conversion of "Cold" Tumors to "Hot" Tumors with ImmunoPulse® IL-12 and Pembrolizumab Combination Therapy
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.